Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55

→ Gold Mania (From Stansberry Research) (Ad)

Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report)'s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $338.55, but opened at $281.55. Bio-Rad Laboratories shares last traded at $279.91, with a volume of 400 shares traded.

Bio-Rad Laboratories Stock Performance

The company has a debt-to-equity ratio of 0.14, a quick ratio of 4.34 and a current ratio of 5.83. The company has a market capitalization of $7.98 billion, a P/E ratio of -13.03 and a beta of 0.66. The firm has a 50 day moving average price of $329.92 and a two-hundred day moving average price of $318.71.

Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last posted its quarterly earnings data on Thursday, February 15th. The company reported $3.10 earnings per share for the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%. The firm had revenue of $681.18 million during the quarter.

Bio-Rad Laboratories Company Profile

(Get Free Report)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

See Also

Should you invest $1,000 in Bio-Rad Laboratories right now?

Before you consider Bio-Rad Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.

While Bio-Rad Laboratories currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Featured Articles and Offers

Search Headlines: